Recent advances in viral hepatitisFOSTER, Graham R.Clinical medicine. 2009, Vol 9, Num 6, pp 613-616, issn 1470-2118, 4 p.Article

Diagnosis and treatment of hepatitis CD'SOUZA, Raymond; FOSTER, Graham R.Journal of the Royal Society of Medicine. 2004, Vol 97, Num 5, pp 223-225, issn 0141-0768, 3 p.Article

Diagnosis and treatment of chronic hepatitis BD'SOUZA, Raymond; FOSTER, Graham R.Journal of the Royal Society of Medicine. 2004, Vol 97, Num 7, pp 318-321, issn 0141-0768, 4 p.Article

Global hepatitis, migration and its impact on Western healthcareAHMED, Furqaan; FOSTER, Graham R.Gut. 2010, Vol 59, Num 8, pp 1009-1011, issn 0017-5749, 3 p.Article

Health-related quality of life before, during and after combination therapy with interferon and ribavirin in unselected swedish patients with chronic hepatitis CHOLLANDER, Anna; FOSTER, Graham R; WEILAND, Ola et al.Scandinavian journal of gastroenterology. 2006, Vol 41, Num 5, pp 577-585, issn 0036-5521, 9 p.Article

Cost-Effectiveness of Hepatitis C Virus Antiviral Treatment for Injection Drug User PopulationsMARTIN, Natasha K; VICKERMAN, Peter; MINERS, Alec et al.Hepatology (Baltimore, Md.). 2012, Vol 55, Num 1, pp 49-57, issn 0270-9139, 9 p.Article

Dengue virus inhibits alpha interferon signaling by reducing STAT2 expressionJONES, Meleri; DAVIDSON, Andrew; HIBBERT, Linda et al.Journal of virology. 2005, Vol 79, Num 9, pp 5414-5420, issn 0022-538X, 7 p.Article

Hepatitis C and cognitive impairment in a cohort of patients with mild liver diseaseFORTON, Daniel M; THOMAS, Howard C; MURPHY, Christine A et al.Hepatology (Baltimore, Md.). 2002, Vol 35, Num 2, pp 433-439, issn 0270-9139Article

Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South AfricaMARTINI, Natasha K; DEVINE, Angela; EATON, Jeffrey W et al.AIDS (London). 2014, Vol 28, issn 0269-9370, S35-S46, SUP1Article

Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 developmentMITCHELL, Peter; GERMAIN, Conrad; FIORI, Pier Luigi et al.Infection and immunity. 2007, Vol 75, Num 2, pp 810-819, issn 0019-9567, 10 p.Article

Phase 2b Trial of Interferon-free Therapy for Hepatitis C Virus Genotype 1KOWDLEY, Kris V; LAWITZ, Eric; WANGANG XIE et al.The New England journal of medicine. 2014, Vol 370, Num 3, pp 222-232, issn 0028-4793, 11 p.Article

Cryptosporidium parvum Infection Rapidly Induces a Protective Innate Immune Response Involving Type I InterferonBARAKAT, Farah M; MCDONALD, Vincent; FOSTER, Graham R et al.The Journal of infectious diseases. 2009, Vol 200, Num 10, pp 1548-1555, issn 0022-1899, 8 p.Article

Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirinFOSTER, Graham R; FRIED, Michael W; HADZIYANNIS, Stephanos J et al.Scandinavian journal of gastroenterology. 2007, Vol 42, Num 2, pp 247-255, issn 0036-5521, 9 p.Article

Randomized clinical trial: a pilot study investigating the safety and effectiveness of an escalating dose of peginterferon α-2a monotherapy for 48 weeks compared with standard clinical care in patients with hepatitis C cirrhosisTANWAR, Sudeep; WRIGHT, Mark; FOSTER, Graham R et al.European journal of gastroenterology & hepatology. 2012, Vol 24, Num 5, pp 543-550, issn 0954-691X, 8 p.Article

The Protease Inhibitor, GS-9256, and Non-Nucleoside Polymerase Inhibitor Tegobuvir Alone, With Ribavirin, or Pegyrlated Interferon Plus Ribavirin in Hepatitis CZEUZEM, Stefan; BUGGISCH, Peter; ARTERBURN, Sarah et al.Hepatology (Baltimore, Md.). 2012, Vol 55, Num 3, pp 749-758, issn 0270-9139, 10 p.Article

Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statementSCHAEFER, Martin; CAPURON, Lucile; FRIEBE, Astrid et al.Journal of hepatology. 2012, Vol 57, Num 6, pp 1379-1390, issn 0168-8278, 12 p.Article

Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utilityMARTIN, Natasha K; VICKERMAN, Peter; FOSTER, Graham R et al.Journal of hepatology. 2011, Vol 54, Num 6, pp 1137-1144, issn 0168-8278, 8 p.Article

Telaprevir for Retreatment of HCV InfectionZEUZEM, Stefan; ANDREONE, Pietro; FERENCI, Peter et al.The New England journal of medicine. 2011, Vol 364, Num 25, pp 2417-2428, issn 0028-4793, 12 p.Article

Combination therapy with amantadine and interferon in naive patients with chronic hepatitis C: meta-analysis of individual patient data from six clinical trialsMANGIA, Alessandra; LEANDRO, Gioacchino; DI MARCO, Vito et al.Journal of hepatology. 2004, Vol 40, Num 3, pp 478-483, issn 0168-8278, 6 p.Article

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 InfectionAFDHAL, Nezam; ZEUZEM, Stefan; FOSTER, Graham R et al.The New England journal of medicine. 2014, Vol 370, Num 20, pp 1889-1898, issn 0028-4793, 10 p.Article

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trialJACOBSON, Ira M; DORE, Gregory J; OUWERKERK-MAHADEVAN, Sivi et al.Lancet (British edition). 2014, Vol 384, Num 9941, pp 403-413, issn 0140-6736, 11 p.Article

HCV genotype-3a T cell immunity: specificity, function and impact of therapyHUMPHREYS, Isla S; DELFT, Annette Von; BROWN, Anthony et al.Gut. 2012, Vol 61, Num 11, pp 1589-1599, issn 0017-5749, 11 p.Article

Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3THOMPSON, Alexander J; PATEL, Keyur; FOSTER, Graham R et al.Gut. 2012, Vol 61, Num 1, pp 128-134, issn 0017-5749, 7 p.Article

Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patientsPATEL, Keyur; THOMPSON, Alexander J; CHO, Mong et al.Journal of gastroenterology and hepatology. 2011, Vol 26, Num 7, pp 1182-1188, issn 0815-9319, 7 p.Article

Response to antiviral therapy in patients with genotype 3 chronic hepatitis C: fibrosis but not race encourages relapseSHOEB, Dania; ROWE, Ian A; FRESHWATER, Dennis et al.European journal of gastroenterology & hepatology. 2011, Vol 23, Num 9, pp 747-753, issn 0954-691X, 7 p.Article